Medpace Holdings (MEDP) Net Cash Flow Growth (5y) (2020 - 2026)
Medpace Holdings (MEDP) Net Cash Flow Growth (5y) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.44 Bn | 209.37 Bn | 8.34 Bn |
| 2 | Danaher | 139.95 Bn | 135.60 Bn | 3.61 Bn |
| 3 | Idexx Laboratories | 46.16 Bn | 45.96 Bn | 779.09 Mn |
| 4 | Agilent Technologies | 39.67 Bn | 37.87 Bn | 990.00 Mn |
| 5 | Iqvia Holdings | 39.29 Bn | 37.21 Bn | 1.44 Bn |
| 6 | Natera | 38.61 Bn | 37.51 Bn | 696.04 Mn |
| 7 | Illumina | 29.99 Bn | 28.82 Bn | 770.00 Mn |
| 8 | Mettler Toledo International | 28.57 Bn | 28.51 Bn | 650.22 Mn |
| 9 | Quest Diagnostics | 26.17 Bn | 25.55 Bn | 1.03 Bn |
| 10 | Medpace Holdings | 16.56 Bn | 16.06 Bn | 201.64 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -93.46% |
| Mar 31, 2026 | 22.67% |
| Dec 31, 2025 | 29.66% |
| Sep 30, 2025 | 32.78% |
| Jun 30, 2025 | -76.22% |
| Mar 31, 2025 | -136.73% |
| Dec 31, 2024 | -22.56% |
| Sep 30, 2024 | 19.30% |
| Jun 30, 2024 | 64.64% |
| Mar 31, 2024 | 86.93% |
| Dec 31, 2023 | 155.27% |
| Sep 30, 2023 | 333.32% |
| Jun 30, 2023 | -52.16% |
| Mar 31, 2023 | 42.40% |
| Dec 31, 2022 | -30.58% |
| Sep 30, 2022 | -7.28% |
| Jun 30, 2022 | -112.13% |
| Mar 31, 2022 | -114.32% |
| Dec 31, 2021 | 25.94% |
| Sep 30, 2021 | 133.35% |